Recent research shows that while both OPN and CA125 rise in ovarian cancer, OPN is better at distinguishing malignant tumors from benign ones, suggesting it could be a useful complement to CA125 for more accurate diagnosis [90]. This evidence concerns the gene MUC16 and ovarian cancer.